Evidence map›Paper›PMID 20398327›Full record

ArticleMolecular pain2010

Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior.

Sacha A Malin, Derek C Molliver

Open access · goldAbstract read
In one paragraph

Article in Molecular pain, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 121 citations in OpenAlex.

  1. Article
  2. Targeting sensory neuron GPCRs for peripheral neuropathic pain.Trends in pharmacological sciences · 2023
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Exploring pharmacological inhibition of GBritish journal of pharmacology · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Calcium Signalling in Breast Cancer Associated Bone Pain.International journal of molecular sciences · 2022
    Review
  14. Review
  15. Article
  16. Update of P2Y receptor pharmacology: IUPHAR Review 27.British journal of pharmacology · 2020
    Review
  17. The role of purinergic P2YPurinergic signalling · 2020
    Article
  18. Article
  19. Review
  20. Activation of spinal dorsal horn P2YJournal of pain research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sacha A MalinDept Medicine; Dept Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA. sachamalin@gmail.com
Derek C Molliver
University of Pittsburgh · US

Funding

Pro- and Anti-Nociceptive Actions of P2y Nucleotide Receptors in Sensory NeuronsR01NS056122 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MOLLIVER, DEREK C · 2007 to 2010
$1.3M
NINDS NIH HHS NINDS NS56122
6 · The paper itself

Abstract

backgroundInvestigations of nucleotide signaling in nociception to date have focused on actions of adenosine triphosphate (ATP). Both ATP-gated ion channels (P2X receptors) and G protein-coupled (P2Y) receptors contribute to nociceptive signaling in peripheral sensory neurons. In addition, several studies have implicated the Gq-coupled adenosine diphosphate (ADP) receptor P2Y1 in sensory transduction. In this study, we examined the expression and function of P2Y1 and the Gi-coupled receptors P2Y12, P2Y13 and P2Y14 in sensory neurons to determine their contribution to nociception.

resultsWe detected mRNA and protein for ADP receptors P2Y12 and P2Y13 in mouse dorsal root ganglia (DRG). P2Y14, a homologous Gi-coupled nucleotide receptor, is also expressed in DRG. Immunohistochemical analysis of receptor distribution indicated that these receptors are widely expressed in nociceptive neurons. Using ratiometric calcium imaging, we found that ADP evokes increases in intracellular calcium in isolated DRG neurons and also produces a pertussis toxin-sensitive inhibition of depolarization-evoked calcium transients. The inhibitory effect of ADP was unaltered in the presence of the selective P2Y1 antagonist MRS2179 and in neurons isolated from P2Y1 knockout mice, whereas ADP-evoked calcium transients were greatly reduced. Analysis of behavioral responses to noxious heat before and after inflammatory injury (injection of complete Freund's adjuvant into the hindpaw) revealed that P2Y1 is required for the full expression of inflammatory hyperalgesia, whereas local injection of agonists for Gi-coupled P2Y receptors reduced hyperalgesia.

conclusionsWe report that Gi-coupled P2Y receptors are widely expressed in peripheral sensory neurons. Agonists for these receptors inhibit nociceptive signaling in isolated neurons and reduce behavioral hyperalgesia in vivo. Anti-nociceptive actions of these receptors appear to be antagonized by the Gq-coupled ADP receptor, P2Y1, which is required for the full expression of inflammatory hyperalgesia. We propose that nociceptor sensitivity is modulated by the integration of nucleotide signaling through Gq- and Gi-coupled P2Y receptors, and this balance is altered in response to inflammatory injury. Taken together, our data suggest that Gi-coupled P2Y receptors are broadly expressed in nociceptors, inhibit nociceptive signaling in vivo, and represent potential targets for the development of novel analgesic drugs.

Indexed as

AnimalsCalciumImmunohistochemistryInflammationMaleMiceMice, Inbred C57BLPainPolymerase Chain ReactionReceptors, Purinergic P2Receptors, Purinergic P2YReceptors, Purinergic P2Y1Receptors, Purinergic P2Y12Sensory Receptor CellsSignal TransductionCalciumP2ry12 protein, mouseP2ry13 protein, mouseP2ry14 protein, mouseP2ry1 protein, mouseReceptors, Purinergic P2Receptors, Purinergic P2YReceptors, Purinergic P2Y1Receptors, Purinergic P2Y12

Identifiers

PMID20398327
PMCPMC2865444
OpenAlexW2021252502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.